Skip to main content
An official website of the United States government

Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Please check the “Other Notices” tab on the NIH Guide for Grants and Contracts to see updates to NIH policies that ensure alignment with the Administration’s priorities.

Parent Announcements (For Unsolicited or Investigator-Initiated Applications)

Parent announcements are broad funding opportunities that applicants can use to submit investigator-initiated applications for a range of popular programs. These announcements do not specify any particular area of scientific interest. They simply provide the standard forms and instructions needed to apply. Parent announcements are open for up to three years and are typically reissued to ensure continuity. They use standard due dates with three application, review, and award cycles each year.

Notice of Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Sort descending Program Official
Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer NOT-CA-22-085 09/08/2025
Notice of Special Interest (NOSI): Targeting the Endocannabinoid System for Brain Health and Acute and Chronic Diseases NOT-DA-22-048 09/08/2025
Notice of Special Interest (NOSI): Factors impacting how Time-Restricted Eating (TRE) influences cancer-related outcomes NOT-CA-24-073 09/08/2025 Edward Sauter, M.D., Ph.D.
Notice of Special Interest (NOSI): Advancing Diet and Physical Activity Biomarkers for Assessing Lifestyle Interventions in Cancer Prevention and Cancer Interception Research NOT-CA-24-074 09/08/2025 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Biology of Bladder Cancer PAR-25-128 (R21 Clinical Trial Optional) R21 Clinical Trial Optional 09/08/2025 Howard L. Parnes, M.D.
Biology of Bladder Cancer PAR-25-129 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 09/08/2025 Howard L. Parnes, M.D.
Notice of Special Interest (NOSI): Mechanisms Driving Obesity and Prostate Cancer Risk NOT-CA-25-002 09/08/2025 Edward Sauter, M.D., Ph.D.
Cancer Prevention and Control Clinical Trials Planning Grant Program PAR-25-104 (R34 Clinical Trials Optional) R34 10/26/2025 Goli Samimi, Ph.D., M.P.H.
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes PAR-25-095 (R01 Clinical Trial Not Allowed) R01 Clinical Trial Not Allowed 09/08/2026 Wendy Wang, Ph.D., M.Sc.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers PAR-23-286 (K99/R00 - Independent Clinical Trial Not Allowed) R00, K99 Clinical Trial Not Allowed 10/15/2026